Factors associated with recruiting an HIV seropositive risk network member among injection drug users

AIDS and Behavior

Volumn 14, Issue 5, 2010, Pages 1137-1141

  Latkin, Carl ^a   Yang, Cui ^a   Tobin, Karin ^a   Hulbert, Alicia ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HIV; HIV testing; Injection drug use; Recruitment; Seropositives; Social network

Indexed keywords

ADULT; ARTICLE; DRUG USE; ETHNIC GROUP; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; RISK; SERODIAGNOSIS; SOCIAL BEHAVIOR; SOCIAL SUPPORT; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE; UNITED STATES;

ADULT; AIDS SERODIAGNOSIS; DRUG USERS; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; RISK; SOCIAL FACILITATION; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 79952112283     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9676-1     Document Type: Article

References (12)

1. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States -implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39: 446-53.
2. Gibson DR, Flynn NM, McCarthy JJ. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 1999;13:1807-18.
3. Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users -a 10-year perspective. Arch Intern Med. 2001;161:1281-8.
4. German D, Davey MA, Latkin CA. Residential transience and HIV risk behaviors among injection drug users. AIDS Behav. 2007;11:S21-30.
5. Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des J. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol. 2000;152:913-22.
6. Neaigus A, Friedman SR, Curtis R, Des J, Furst RT, Jose B, et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994; 38:67-78.
7. Rothenberg RB, Potterat JJ, Woodhouse DE, Muth SQ, Darrow WW, Klovdahl AS. Social network dynamics and HIV transmission. AIDS. 1998;12:1529-36.
8. Latkin CA, Mandell W, Vlahov D. The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: A prospective study. Drug Alcohol Depend. 1996;42:175-81.
9. Vargo S, Agronick G, O'Donnell L, Stueve A. Using peer recruitment and OraSure to increase HIV testing. Am J Public Health. 2004;94:29-31.
10. Rothenberg R, Kimbrough L, Lewis-Hardy R, Heath B, Williams OC, Tambe P, et al. Social network methods for endemic foci of syphilis -a pilot project. Sex Transm Dis. 2000;27:12-8.
11. Kimbrough LW, Fisher HE, Jones KT, Johnson W, Thadiparthi S, Dooley S. Accessing social networks with high rates of undiagnosed HIV infection: the social networks demonstration project. Am J Public Health. 2009;99:1093-9.
12. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1: 385-401.